(Q43290066)

18 November 2017

A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy (English)

1 reference

18 November 2017

6

Peter Reiss

1 reference

18 November 2017

Regje M E Blümer

1

1 reference

18 November 2017

Marc van der Valk

2

1 reference

18 November 2017

Mariette Ackermans

3

1 reference

18 November 2017

Erik Endert

4

1 reference

18 November 2017

Mireille J Serlie

5

1 reference

18 November 2017

Hans P Sauerwein

7

1 reference

18 November 2017

18 August 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

18 November 2017

1 reference

18 November 2017

297

1 reference

18 November 2017

5

1 reference

18 November 2017

E1097-104

1 reference

Adipose tissue as an endocrine organ

18 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Rosiglitazone for HIV-1 lipoatrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Calculation of substrate oxidation rates in vivo from gaseous exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

The effect of pioglitazone on the liver: role of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Fatty acids and insulin resistance in muscle and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Importance of the high-molecular-mass isoform of adiponectin in improved insulin sensitivity with rosiglitazone treatment in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Adipose tissue: from lipid storage compartment to endocrine organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Analytical validation and biological evaluation of a high molecular-weight adiponectin ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Post-translational modifications of adiponectin: mechanisms and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90988.2008

10.1152/AJPENDO.90988.2008

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference